Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers?

Journal of the National Cancer Institute

Volumn 101, Issue 16, 2009, Pages 1103-1105

  Strickler, Howard D ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANUS TUMOR; CANCER REGISTRY; CANCER RISK; CD4 LYMPHOCYTE COUNT; DISEASE ASSOCIATION; EDITORIAL; EPSTEIN BARR VIRUS; HERPES VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; KAPOSI SARCOMA; KIDNEY GRAFT; MALE HOMOSEXUAL; NONHODGKIN LYMPHOMA; OROPHARYNX CANCER; PAPILLOMA VIRUS; PENIS CANCER; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX DISEASE; VAGINA TUMOR; VIRUS CARCINOGENESIS; VULVA CANCER; WART VIRUS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALPHAPAPILLOMAVIRUS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; RISK ASSESSMENT; RISK FACTORS; TUMOR VIRUS INFECTIONS; UNITED STATES;

EID: 69249109991     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp236     Document Type: Editorial

References (41)

1. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men - New York City and California. MMWR Morb Mortal Wkly Rep. 1981;30:305-308.
2. Follow-up on Kaposi's sarcoma and Pneumocystis pneumonia. MMWR Morb Mortal Wkly Rep. 1981;30:409-410.
3. Biggar RJ, Nasca PC, Burnett WS. AIDS-related Kaposi's sarcoma in New York City in 1977. N Engl J Med. 1988;318:252.
4. Ziegler JL, Drew WL, Miner RC, et al. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet. 1982;2:631-633.
5. Ziegler JL, Beckstead JA, Volberding PA, et al. Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodefi ciency syndrome. N Engl J Med. 1984;311:565-570.
6. Update on acquired immune defi ciency syndrome (AIDS) - United States. MMWR Morb Mortal Wkly Rep. 1982;31:507-508. 13-14.
7. Revision of the case defi nition of acquired immunodefi ciency syndrome for national reporting - United States. MMWR Morb Mortal Wkly Rep. 1985;34:373-375.
8. Cheung MC, Pantanowitz L, Dezube BJ. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist. 2005;10:412-426.
9. Cote TR, Howe HL, Anderson SP, Martin RJ, Evans B, Francis BJ. A systematic consideration of the neoplastic spectrum of AIDS: registry linkage in Illinois. AIDS. 1991;5:49-53.
10. Cote TR, O'Brien TR, Ward JW, Wilson SE, Blattner WA. AIDS and cancer registry linkage: measurement and enhancement of registry completeness. The National AIDS/Cancer Match Study Group. Prev Med. 1995;24:375-377.
11. Goedert JJ, Cote TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
12. Frisch M, Biggar RJ, Engels EA, Goedert JJ. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
13. Newnham A, Harris J, Evans HS, Evans BG, Moller H. The risk of cancer in HIV-infected people in southeast England: a cohort study. Br J Cancer. 2005;92:194-200.
14. Dal Maso L, Franceschi S, Polesel J, et al. Risk of cancer in persons with AIDS in Italy, 1985-1998. Br J Cancer. 2003;89:94-100.
15. Galceran J, Marcos-Gragera R, Soler M, et al. Cancer incidence in AIDS patients in Catalonia, Spain. Eur J Cancer. 2007;43:1085-1091.
16. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962-972.
17. Bradbeer C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? Lancet. 1987;2:1277-1278.
18. Maiman M, Fruchter RG, Serur E, Boyce JG. Prevalence of human immunodefi ciency virus in a colposcopy clinic. JAMA. 1988;260:2214-2215.
19. Henry MJ, Stanley MW, Cruikshank S, Carson L. Association of human immunodefi ciency virus-induced immunosuppression with human papillomavirus infection and cervical intraepithelial neoplasia. Am J Obstet Gynecol. 1989;160:352-353.
20. Risk for cervical disease in HIV-infected women - New York City. MMWR Morb Mortal Wkly Rep. 1990;39:846-849.
21. Impact of the expanded AIDS surveillance case defi nition on AIDS case reporting - United States, fi rst quarter, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:308-310.
22. Extension of public comment period for revision of HIV infection classifi cation system and expansion of AIDS surveillance case defi nition. MMWR Morb Mortal Wkly Rep. 1992;40:891.
23. Controversy over defi nition of AIDS cases continues. Nation's Health. 1992;22:1.
24. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodefi ciency virus infection and acquired immunodefi ciency syndrome. J Natl Cancer Inst. 2000;92:1500-1510.
25. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
26. Chaturvedi AK, Madeleine MM, Biggar R, Engels E. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009.
27. Engels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodefi ciency virus in the United States. Int J Cancer. 2008;123:187-194.
28. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355:1886-1887.
29. Kyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int. 2000;13(suppl 1):S394 - S398.
30. Adami J, Gabel H, Lindelof B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer. 2003;89:1221-1227.
31. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296:2823-2831.
32. Villeneuve PJ, Schaubel DE, Fenton SS, Shepherd FA, Jiang Y, Mao Y. Cancer incidence among Canadian kidney transplant recipients. Am J Transplant. 2007;7:941-948.
33. Hessol NA, Pipkin S, Schwarcz S, Cress RD, Bacchetti P, Scheer S. The impact of highly active antiretroviral therapy on non-AIDS-defi ning cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143-1153.
34. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer. 2001;37:1188-1201.
35. Mbulaiteye SM, Katabira ET, Wabinga H, et al. Spectrum of cancers among HIV-infected persons in Africa: the Uganda AIDS-cancer registry match study. Int J Cancer. 2006;118:985-990.
36. Kamal SM, El Sayed Khalifa K. Immune modulation by helminthic infections: worms and viral infections. Parasite Immunol. 2006;28:483-496.
37. Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodefi ciency viruspositive women. J Natl Cancer Inst. 2005;97:577-586.
38. Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defi c Syndr. 2009.
39. Hawes SE, Critchlow CW, Sow PS, et al. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. J Natl Cancer Inst. 2006;98:100-109.
40. Ahdieh L, Klein RS, Burk R, et al. Prevalence, incidence, and type-specifi c persistence of human papillomavirus in human immunodefi ciency virus (HIV)-positive and HIV-negative women. J Infect Dis. 2001;184:682-690.
41. Palefsky JM, Gillison ML, Strickler HD. Chapter 16: HPV vaccines in immunocompromised women and men. Vaccine. 2006;24(suppl 3):S140 - S146.